End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
25.4 CNY | -2.57% | +12.54% | -9.93% |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
Strengths
- Analysts expect a sharply increasing business volume for the group, with high growth rates in the coming years.
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
Weaknesses
- With an expected P/E ratio at 78.15 and 40.97 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- Based on current prices, the company has particularly high valuation levels.
- The company appears highly valued given the size of its balance sheet.
- The company is not the most generous with respect to shareholders' compensation.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Sector: Commodity Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-9.93% | 920M | - | ||
+5.97% | 105B | A- | ||
-4.19% | 63.99B | A- | ||
+51.90% | 42.95B | B | ||
+17.44% | 39.2B | B | ||
+6.62% | 33.01B | A- | ||
+13.00% | 20.33B | B- | ||
+15.64% | 17.29B | C+ | ||
+22.55% | 15.72B | B- | ||
+7.34% | 14.72B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 605376 Stock
- Ratings Jiangsu Boqian New Materials Stock Co., Ltd.